By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “SYNC OR SINK” by Cheryl Liljestrand, representing Therapeutic Proteins International. This application was made available to the public on June 27, 2014 (see also Trademarks).
The serial number for this application is 86309329.
The international trademark goods and services class code for this trademark application is 009.
As submitted by the applicant, this trademark application relates to the following goods and services: Tool for coordinating workflow around departments to improve efficiency and productivity.
The owner/registrar information for this application is: Cheryl Liljestrand, Therapeutic Proteins International, 3440 S Dearborn St Ste 300, Chicago, IL 60616-5149.
Keywords for this news article include: Trademarks, Therapeutic Proteins International.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
An Application for the Trademark “SYNC OR SINK” Has Been Filed by Therapeutic Proteins International
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
AT&T, T-Mobile and Verizon should be turning the volume up. Their current quiet murmur is just not enough.
If you don't feel that U.S. culture (and much of the world in different ways) is in turmoil, you are not paying attention.
When the Fed begins to lower rates and the greenback cools, I believe dollar-denominated gold will shine. Investment in gold and mining stocks is another matter.
As we say goodbye to 2023, there's a compelling argument to keep your portfolio anchored in growth stocks next year.
BLS and the airlines are measuring different things: CPI allegedly measures average change in prices paid; RASM is an industry efficiency metric.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
